Direct Healthcare has bought Transflo Cushion from Karomed in a deal advised on by HURST Corporate Finance.

Direct Healthcare manufactures pressure care goods from its headquarters in Caerphilly. Insider Media reports the deal for Transflo Cushion is its third bolt on acquisition since private equity firm NorthEdge Capital backed the business in a management buyout in April 2016. The product has been in the pressure care market for more than thirty years and is used in acute and community care settings. Direct Healthcare will assume all sales of the cushion following the transaction.

Graham Ewart, chief executive of Direct Healthcare, said “By increasing our product offering we ensure that we are providing innovative, market-leading pressure care management that makes a real difference to our healthcare professionals and the patients they provide care for. DHG’s global network will allow the Transflo Cushion range to be offered across Europe and Asia-Pacific for the first time, providing a strongly regarded, high-risk preventative product worldwide. This represents our continued intent to deliver pressure care solutions that provide value and benefit to our healthcare providers.”

Karomed managing director, Emma Teasdale, said “We have been extremely proud of the development and popularity of the Transflo Cushion within the UK market. Direct Healthcare can now take this a step further.”

HURST Corporate Finance partner Nigel Barratt and corporate finance manager Ben Bradley advised Karomed on the transaction, with Paul Johnson and Rachel Clarkson of Ward Hadaway providing legal advice. Ben Bradley said “The Transflo Cushion is an extremely popular and proven product which has significant potential for growth. Its sale will enable the Transflo brand to achieve its full potential and allow Karomed to focus on its other products.”

Andrew Skinner, investment manager at NorthEdge Capital, said “The team at DHG has continued to grow the business both organically and through the acquisition of specialist products and brands. This latest deal adds to the group’s diverse portfolio and supports further its growth in the healthcare market.”